MERRIMACK PHARMACEUTICALS IN

Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for MERRIMACK PHARMACEUTICALS IN NOTE 4.500% 7/1, CUSIP 590328AA8.